United States Radiopharmaceutical Industry 2017 Market Research Report
- QYR1359878
- 124 Pages
- July 2017
- Healthcare
In the last several years, United States market of Radiopharmaceuticals developed smoothly, with an average growth rate of 6.7%. In 2016, United States revenue of Radiopharmaceuticals is nearly 2100 million USD.
The major players in United States Radiopharmaceuticals market include
Bayer
Triad Isotopes
Lantheus
GE Healthcare
Mallinckrodt
Eli Lilly
Bracco Imaging
SIEMENS
Navidea
Nordion
IBA Group
Jubilant Pharma
Geographically, this report is segmented into several key Regions, with Sales, revenue, Market Share (%) and Growth Rate (%) of Radiopharmaceuticals in these regions, from 2012 to 2022 (forecast), covering
Mid-Atlantic Region
South Atlantic
West South Central
Pacific Region
Other
On the basis of product, the Radiopharmaceuticals market is primarily split into
SPECT Radioisotopes
PET Radioisotopes
Other Diagnostic Radioisotopes
Therapeutic Radioisotopes
On the basis on the end applications, this report covers
Oncology
Cardiology
Other
1 Radiopharmaceutical Overview 1
1.1 Product Overview and Scope of Radiopharmaceutical 1
1.1.1 Product Overview 1
1.1.2 Specifications of Radiopharmaceuticals 1
1.2 Classification of Radiopharmaceutical by Product Category 3
1.3 Applications of Radiopharmaceuticals 5
1.3.1 Oncology 6
1.3.2 Cardiology 7
1.3.3 Other 8
1.4 United States Radiopharmaceuticals Market by Regions (2012-2022) 8
1.4.1 United States Radiopharmaceuticals Market Size and Growth (%) Comparison by Regions (2012-2022) 8
1.4.2 Mid-Atlantic Region Radiopharmaceuticals Status and Prospect (2012-2022) 9
1.4.3 South Atlantic Radiopharmaceuticals Status and Prospect (2012-2022) 10
1.4.4 West South Central Radiopharmaceuticals Status and Prospect (2012-2022) 11
1.4.5 Pacific Region Radiopharmaceuticals Status and Prospect (2012-2022) 12
1.5 United States Radiopharmaceuticals Market Size (2012-2022) 13
1.5.1 United States Radiopharmaceuticals Revenue Status and Outlook (2012-2022) 13
1.5.2 United States Radiopharmaceuticals Sales Status and Outlook (2012-2022) 14
2 United States Radiopharmaceuticals Market Competition by Manufacturers/Brand 15
2.1 United States Radiopharmaceuticals Sales and Share by Manufacturers (2016-2017) 15
2.2 United States Radiopharmaceuticals Revenue and Share by Manufacturers (2016-2017) 17
2.3 United States Radiopharmaceuticals Average Price by Manufacturers (2016-2017) 20
2.4 Radiopharmaceuticals Market Competitive Situation and Trends 23
2.4.1 Radiopharmaceuticals Market Concentration Rate 23
2.4.2 Radiopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers 24
2.4.3 Mergers & Acquisitions, Expansion in United States Market 25
2.5 United States Players/Manufacturers Radiopharmaceutical Headquarter & R&D 27
3 United States Radiopharmaceuticals Sales, Revenue by Regions (2012-2017) 29
3.1 United States Radiopharmaceuticals Sales and Market Share by Regions (2012-2017) 29
3.2 United States Radiopharmaceuticals Revenue and Market Share by Regions (2012-2017) 31
3.3 United States Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 33
3.4 United States Cyclotrons Install Base Dedicated to the Production of Medical Radionuclides (2015-2016) 33
3.5 Mid-Atlantic Region Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 33
3.6 South Atlantic Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 34
3.7 West South Central Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 34
3.8 Pacific Region Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 35
4 United States Radiopharmaceuticals Sales, Revenue, Price Trend by Types 36
4.1 United States Radiopharmaceuticals Sales and Market Share by Types (2012-2017) 36
4.2 United States Radiopharmaceuticals Revenue and Market Share by Types (2012-2017) 38
4.3 United States Radiopharmaceuticals Price by Type (2012-2017) 40
4.4 United States Radiopharmaceuticals Sales Growth by Type (2012-2017) 40
5 United States Radiopharmaceuticals Market Analysis by Applications 41
5.1 United States Radiopharmaceuticals Sales and Market Share by Applications (2012-2017) 41
5.2 United States Radiopharmaceuticals Sales Growth Rate by Applications (2012-2017) 43
6 Major Manufacturers Analysis of Radiopharmaceuticals 44
6.1 Bayer 44
6.1.1 Company Profile 44
6.1.2 Product Information 45
6.1.3 Sales, Price, Cost, Gross, and Revenue 45
6.2 Triad Isotopes 46
6.2.1 Company Profile 46
6.2.2 Product Information 47
6.2.3 Sales, Price, Cost, Gross, and Revenue 47
6.3 Lantheus Medical Imaging 48
6.3.1 Company Profile 48
6.3.2 Product Information 49
6.3.3 Sales, Price, Cost, Gross, and Revenue 49
6.4 GE Healthcare 50
6.4.1 Company Profile 50
6.4.2 Product Information 51
6.4.3 Sales, Price, Cost, Gross, and Revenue 51
6.5 Mallinckrodt 52
6.5.1 Company Profile 52
6.5.2 Product Information 53
6.5.3 Sales, Price, Cost, Gross, and Revenue 53
6.6 Eli Lilly 54
6.6.1 Company Profile 54
6.6.2 Product Information 55
6.6.3 Sales, Price, Cost, Gross, and Revenue 55
6.7 Bracco Imaging 56
6.7.1 Company Profile 56
6.7.2 Product Information 57
6.7.3 Sales, Price, Cost, Gross, and Revenue 58
6.8 SIEMENS 58
6.8.1 Company Profile 58
6.8.2 Product Information 59
6.8.3 Sales, Price, Cost, Gross, and Revenue 60
6.9 Navidea 60
6.9.1 Company Profile 60
6.9.2 Product Information 61
6.9.3 Sales, Price, Cost, Gross, and Revenue 62
6.10 Nordion 62
6.10.1 Company Profile 62
6.10.2 Product Information 63
6.10.3 Sales, Price, Cost, Gross, and Revenue 64
6.11 IBA Group 64
6.11.1 Company Profile 64
6.11.2 Product Information 65
6.11.3 Sales, Price, Cost, Gross, and Revenue 66
6.12 Jubilant Pharma 66
6.12.1 Company Profile 66
6.12.2 Product Information 68
6.12.3 Sales, Price, Cost, Gross, and Revenue 69
7 Radiopharmaceutical Manufacturing Cost Analysis 70
7.1 Radiopharmaceutical Key Raw Materials Analysis 70
7.2 Proportion of Manufacturing Cost Structure 70
7.2.1 Raw Materials 71
7.2.2 Labor Cost Analysis of Radiopharmaceuticals 71
7.2.3 Other Costs Analysis 73
7.2.4 Manufacturing Expenses 73
7.3 Manufacturing Process Analysis of Radiopharmaceutical 74
7.4 Equipment Suppliers Analysis of Radiopharmaceuticals 74
8 Industrial Chain, Sourcing Strategy and Downstream Buyers 76
8.1 Radiopharmaceutical Industrial Chain Analysis 76
8.2 Upstream Raw Materials Sourcing 77
8.3 Downstream Buyers 77
9 Marketing Strategy Analysis, Distributors/Traders 79
9.1 Marketing Channel 79
9.1.1 Direct Marketing 79
9.1.2 Indirect Marketing 80
9.1.3 Marketing Channel Development Trend 80
9.2 Market Positioning 81
9.2.1 Pricing Strategy 81
9.2.2 Brand Strategy 82
9.2.3 Target Client 83
9.3 Distributors/Traders List 83
10 Market Effect Factors Analysis 85
10.1 Technology Progress/Risk 85
10.1.1 Substitutes Threat 85
10.1.2 Technology Progress in Related Industry 86
10.2 Consumer Needs/Customer Preference Change 87
10.2.1 Cancer Patients Analysis 87
10.2.2 Cardiology Patients Analysis 89
10.3 Economic/Political Environmental Change 91
11 United States Radiopharmaceuticals Market Forecast (2017-2022) 94
11.1 United States Radiopharmaceuticals Sales, Revenue Forecast (2017-2022) 94
11.1.1 United States Radiopharmaceuticals Sales and Growth Rate Forecast (2017-2022) 94
11.1.2 United States Radiopharmaceuticals Revenue and Growth Rate Forecast (2017-2022) 95
11.1.3 United States Radiopharmaceuticals Price and Trend Forecast (2017-2022) 96
11.2 United States Radiopharmaceuticals Sales and Revenue Forecast by Regions (2017-2022) 96
11.2.1 Mid-Atlantic Region Radiopharmaceuticals Sales and Revenue Forecast (2017-2022) 97
11.2.2 South Atlantic Radiopharmaceuticals Sales and Revenue Forecast (2017-2022) 98
11.2.3 West South Central Radiopharmaceuticals Sales and Revenue Forecast (2017-2022) 99
11.2.4 Pacific Region Radiopharmaceuticals Sales and Revenue Forecast (2017-2022) 100
11.3 United States Radiopharmaceuticals Sales Forecast by Type (2017-2022) 101
11.4 United States Radiopharmaceuticals Sales Forecast by Application (2017-2022) 102
12 Research Findings and Conclusion 104
13 Appendix 105
13.1 Methodology/Research Approach 105
13.1.1 Research Programs/Design 105
13.1.2 Market Size Estimation 106
13.1.3 Market Breakdown and Data Triangulation 107
13.2 Data Source 108
13.2.1 Secondary Sources 108
13.2.2 Primary Sources 109
13.3 Disclaimer 110
13.4 Author List 112
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
